It appears to be sour grapes as AERN backed out of that deal after doing some extensive DD and felt the price/reward was way out of line. I suspect we will be getting an update from Stan on this issue. I am told REHOBOTH was thought to be of better value for the stockholders and that was closed instead.
Market Data 
Markets 
AI
